Ligand validation:3QLP

0G6: D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide

0G6 is a Ligand Of Interest in 3QLP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3QLP_0G6_H_1	66%	13%	0.123	0.929	1.56	2.57	2	6	1	0	100%	0.9677
4CH2_0G6_B_1001	96%	42%	0.068	0.975	1.09	1.23	2	4	3	0	100%	0.9677
6EO6_0G6_H_701	96%	44%	0.069	0.976	1.06	1.12	2	5	0	0	100%	0.9677
4LZ1_0G6_L_301	94%	37%	0.073	0.972	1.23	1.34	3	4	0	0	100%	0.9677
6Z8V_0G6_H_301	94%	34%	0.076	0.974	1.21	1.51	2	7	0	0	100%	0.9677
1SHH_0G6_E_301	92%	58%	0.069	0.958	0.84	0.77	1	1	0	0	100%	0.9677
5JBA_0G6_S_302	96%	24%	0.065	0.973	1.91	1.4	8	4	0	0	100%	0.9677
5JB9_0G6_S_301	94%	33%	0.063	0.96	1.68	1.11	5	1	0	0	100%	0.9677

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.